{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T17:18:15Z","timestamp":1774459095962,"version":"3.50.1"},"reference-count":47,"publisher":"Spandidos Publications","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.3892\/mmr.2015.3637","type":"journal-article","created":{"date-parts":[[2015,4,16]],"date-time":"2015-04-16T12:40:23Z","timestamp":1429188023000},"page":"1717-1726","source":"Crossref","is-referenced-by-count":27,"title":["Effectiveness of combined salmon calcitonin and aspirin therapy for osteoporosis in ovariectomized rats"],"prefix":"10.3892","volume":"12","author":[{"given":"JINSONG","family":"WEI","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JIAN","family":"WANG","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"YAN","family":"GONG","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"RONG","family":"ZENG","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2015,4,16]]},"reference":[{"key":"key20180108022051_b1-mmr-12-02-1717","doi-asserted-by":"crossref","first-page":"3318","DOI":"10.1172\/JCI27071","article-title":"Pathogenesis of osteoporosis: concepts, conflicts, and prospects","volume":"115","author":"Raisz","year":"2005","journal-title":"J Clin Invest"},{"key":"key20180108022051_b2-mmr-12-02-1717","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1196\/annals.1346.047","article-title":"Interactive effect of interleukin-6 and prostaglandin E2 on osteoclastogenesis via the OPG\/RANKL\/RANK system","volume":"1068","author":"Liu","year":"2006","journal-title":"Ann NY Acad Sci"},{"key":"key20180108022051_b3-mmr-12-02-1717","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.abb.2008.03.018","article-title":"Functions of RANKL\/RANK\/OPG in bone modeling and remodeling","volume":"473","author":"Boyce","year":"2008","journal-title":"Arch Biochem Biophys"},{"key":"key20180108022051_b4-mmr-12-02-1717","doi-asserted-by":"crossref","first-page":"7260","DOI":"10.1073\/pnas.87.18.7260","article-title":"Origin of osteoclasts: mature monocytes and macrophages are capable of differentiating into osteoclasts under a suitable microenvironment prepared by bone marrow-derived stromal cells","volume":"87","author":"Udagawa","year":"1990","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20180108022051_b5-mmr-12-02-1717","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1038\/46303","article-title":"Activated T cells regulate bone loss and join destruction in adjuvant arthritis through osteoprotegerin ligand","volume":"402","author":"Kung","year":"1999","journal-title":"Nature"},{"key":"key20180108022051_b6-mmr-12-02-1717","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0092-8674(00)80209-3","article-title":"Osteoprotegerin: a novel secreted protein involved in the regulation of bone density","volume":"89","author":"Simonet","year":"1997","journal-title":"Cell"},{"key":"key20180108022051_b7-mmr-12-02-1717","first-page":"E2","article-title":"Postmenopausal hormone replacement therapy and breast cancer","volume":"5","author":"Jacobs","year":"2000","journal-title":"Medscape Women\u2019s Health"},{"key":"key20180108022051_b8-mmr-12-02-1717","doi-asserted-by":"crossref","first-page":"689","DOI":"10.7326\/0003-4819-132-9-200005020-00002","article-title":"Postmenopausal hormone therapy increases risk for venous thromboembolic disease. The heart and estrogen\/progestin replacement study","volume":"132","author":"Grady","year":"2000","journal-title":"Ann Intern Med"},{"key":"key20180108022051_b9-mmr-12-02-1717","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1001\/jama.288.3.321","article-title":"Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women\u2019s Health Initiative randomized controlled trial","volume":"288","author":"Rossouw","year":"2002","journal-title":"JAMA"},{"key":"key20180108022051_b10-mmr-12-02-1717","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1359\/jbmr.1998.13.4.581","article-title":"Nitrogen-containing bisphosphonates inhibit the mevalonate pathway and prevent post-translational prenylation of GTP-binding proteins, including Ras","volume":"13","author":"Luckman","year":"1998","journal-title":"J Bone Miner Res"},{"key":"key20180108022051_b11-mmr-12-02-1717","first-page":"273","article-title":"Bisphosphonate-associated osteonecrosis of the jaws \u2013 report of three cases in Bulgaria and review of the literature","volume":"50","author":"Pechalova","year":"2011","journal-title":"Acta Clin Croat"},{"key":"key20180108022051_b12-mmr-12-02-1717","doi-asserted-by":"crossref","first-page":"24193","DOI":"10.1074\/jbc.M603528200","article-title":"Structural determinants of salmon calcitonin bioactivity: The role of the Leu-based amphipathic alpha-helix","volume":"281","author":"Andreotti","year":"2006","journal-title":"J Biol Chem"},{"key":"key20180108022051_b13-mmr-12-02-1717","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/s002239900262","article-title":"Calcitonin provides complete protection against cancellous bone loss in the femoral neck of ovariectomized rats","volume":"60","author":"Shen","year":"1997","journal-title":"Calcif Tissue Int"},{"key":"key20180108022051_b14-mmr-12-02-1717","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s00774-005-0612-9","article-title":"Effects of combined elcatonin and alendronate treatment on the architecture and strength of bone in ovariectomized rats","volume":"23","author":"Ogawa","year":"2005","journal-title":"J Bone Miner Metab"},{"issue":"Suppl 2","key":"key20180108022051_b15-mmr-12-02-1717","doi-asserted-by":"crossref","first-page":"S37","DOI":"10.1016\/8756-3282(92)90195-3","article-title":"Management of high turnover osteoporosis with calcitonin","volume":"13","author":"Reginster","year":"1992","journal-title":"Bone"},{"key":"key20180108022051_b16-mmr-12-02-1717","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1007\/BF00433930","article-title":"Effects of acetylsalicylic acid on heterotopic bone resorption and formation in rats","volume":"105","author":"Solheim","year":"1986","journal-title":"Arch Orthop Trauma Surg"},{"key":"key20180108022051_b17-mmr-12-02-1717","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1359\/jbmr.2003.18.10.1795","article-title":"Association between bone mineral density and the use of nonsteroidal anti-inflammatory drugs and aspirin: impact of cyclooxygenase selectivity","volume":"18","author":"Carbone","year":"2003","journal-title":"J Bone Miner Res"},{"key":"key20180108022051_b18-mmr-12-02-1717","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1007\/s00198-011-1692-0","article-title":"Effects of paracetamol, nonsteroidal anti-inflammatory drugs, acetylsalicylic acid and opioids on bone mineral density and risk of fracture: results of the Danish Osteoporosis Prevention Study (DOPS)","volume":"23","author":"Vestergaard","year":"2012","journal-title":"Osteoporos Int"},{"key":"key20180108022051_b19-mmr-12-02-1717","doi-asserted-by":"crossref","first-page":"3678","DOI":"10.4049\/jimmunol.156.10.3678","article-title":"Concanamycin A, a powerful tool for characterization and estimation of contribution of perforin- and Fas-based lytic pathways in cell-mediated cytotoxicity","volume":"156","author":"Kataoka","year":"1996","journal-title":"J Immunol"},{"key":"key20180108022051_b20-mmr-12-02-1717","doi-asserted-by":"crossref","first-page":"e2615","DOI":"10.1371\/journal.pone.0002615","article-title":"Pharmacologic stem cell based intervention as a new approach to osteoporosis treatment in rodents","volume":"3","author":"Yamaza","year":"2008","journal-title":"PLoS One"},{"key":"key20180108022051_b21-mmr-12-02-1717","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1034\/j.1600-0447.2002.11227.x","article-title":"Sequential expressions of MMP-1, TIMP-1, IL-6, and COX-2 genes in induced periapical lesions in rats","volume":"110","author":"Lin","year":"2002","journal-title":"Eur J Oral Sci"},{"key":"key20180108022051_b22-mmr-12-02-1717","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/0169-6009(92)90809-R","article-title":"On the rat model of human osteopenias and osteoporoses","volume":"18","author":"Frost","year":"1992","journal-title":"Bone Miner"},{"key":"key20180108022051_b23-mmr-12-02-1717","first-page":"678","article-title":"Tanshinone prevents cancellous bone loss induced by ovariectomy in rats","volume":"25","author":"Cui","year":"2004","journal-title":"Acta Pharmacol Sin"},{"key":"key20180108022051_b24-mmr-12-02-1717","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1136\/jcp.2005.026534","article-title":"Expression of osteoprotegerin (OPG), TNF related apoptosis inducing ligand (TRAIL) and receptor activator of nuclear factor \u03baB ligand (RANKL) in human breast tumours","volume":"59","author":"Van Poznak","year":"2006","journal-title":"J Clin Pathol"},{"key":"key20180108022051_b25-mmr-12-02-1717","unstructured":"LowryFFDA panel says to stop marketing salmon calcitonin for osteoporosisMedscape Medical NewsMarch62013http:\/\/www.medscape.com\/viewarticle\/780323. Accessed August 10, 2013"},{"key":"key20180108022051_b26-mmr-12-02-1717","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1002\/psb.907","article-title":"Quality and outcomes framework indicators for osteoporosis","volume":"23","author":"Byrne","year":"2012","journal-title":"Prescriber"},{"key":"key20180108022051_b27-mmr-12-02-1717","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.bone.2011.05.022","article-title":"Eldecalcitol, a second-generation vitamin D analog, drives bone minimodeling and reduces osteoclastic number in trabecular bone of ovariectomized rats","volume":"49","author":"de Freitas","year":"2011","journal-title":"Bone"},{"key":"key20180108022051_b28-mmr-12-02-1717","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1002\/jbmr.5650090802","article-title":"The diagnosis of osteoporosis","volume":"9","author":"Kanis","year":"1994","journal-title":"J Bone Miner Res"},{"key":"key20180108022051_b29-mmr-12-02-1717","first-page":"47","article-title":"Calcitonin versus clodronate in the prevention of ovariectomy-induced osteopenia in rats","volume":"19","author":"Rico","year":"2000","journal-title":"Clin Rheumatol"},{"key":"key20180108022051_b30-mmr-12-02-1717","doi-asserted-by":"crossref","first-page":"508","DOI":"10.3349\/ymj.2003.44.3.508","article-title":"A comparison of estrogen and two different doses of calcitonin in ovariectomized rats","volume":"44","author":"Kavuncu","year":"2003","journal-title":"Yonsei Med J"},{"key":"key20180108022051_b31-mmr-12-02-1717","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1097\/01.rhu.0000208612.33819.8c","article-title":"Important determinants of bone strength: beyond bone mineral density","volume":"12","author":"Friedman","year":"2006","journal-title":"J Clin Rheumatol"},{"key":"key20180108022051_b32-mmr-12-02-1717","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1001\/jama.285.6.785","article-title":"Osteoporosis prevention, diagnosis, and therapy","volume":"285","author":"NIH Consensus Development Panel on Osteoporosis Prevention, Diagnosis, and Therapy","year":"2001","journal-title":"JAMA"},{"key":"key20180108022051_b33-mmr-12-02-1717","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/8756-3282(89)90145-2","article-title":"Flurbiprofen enhances growth and cancellous and cortical bone accumulation in rapidly growing long bones","volume":"10","author":"Li","year":"1989","journal-title":"Bone"},{"key":"key20180108022051_b34-mmr-12-02-1717","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/8756-3282(95)80027-N","article-title":"Temporal changes in cancellous bone structure of rats immediately after ovariectomy","volume":"16","author":"Dempster","year":"1995","journal-title":"Bone"},{"key":"key20180108022051_b35-mmr-12-02-1717","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/8756-3282(96)00014-2","article-title":"A comparison of the skeletal effects of intermittent and continuous administration of calcitonin in ovariectomized rats","volume":"18","author":"Li","year":"1996","journal-title":"Bone"},{"key":"key20180108022051_b36-mmr-12-02-1717","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1359\/jbmr.2001.16.3.457","article-title":"Mechanical consequences of bone loss in cancellous bone","volume":"16","author":"van der Linden","year":"2001","journal-title":"J Bone Miner Res"},{"key":"key20180108022051_b37-mmr-12-02-1717","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1016\/j.jbiomech.2008.03.025","article-title":"Some basic relationships between density values in cancellous and cortical bone","volume":"41","author":"Zioupos","year":"2008","journal-title":"J Biomech"},{"key":"key20180108022051_b38-mmr-12-02-1717","doi-asserted-by":"crossref","first-page":"105","DOI":"10.3343\/alm.2012.32.2.105","article-title":"Current recommendations for laboratory testing and use of bone turnover markers in management of osteoporosis","volume":"32","author":"Lee","year":"2012","journal-title":"Ann Lab Med"},{"key":"key20180108022051_b39-mmr-12-02-1717","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1507\/endocrj.47.103","article-title":"Age-related changes in bone mineral density and serum bone-related proteins in premenopausal and postmenopausal Japanese women","volume":"47","author":"Yasumizu","year":"2000","journal-title":"Endocr J"},{"key":"key20180108022051_b40-mmr-12-02-1717","first-page":"345","article-title":"Receptor activator of nuclear factor-\u03baB ligand and osteoprotegerin: maintaining the balance to prevent bone loss","volume":"5","author":"Trouvin","year":"2010","journal-title":"Clin Interv Aging"},{"key":"key20180108022051_b41-mmr-12-02-1717","doi-asserted-by":"crossref","first-page":"6773","DOI":"10.1016\/j.biomaterials.2011.05.080","article-title":"The balance between adipogenesis and osteogenesis in bone regeneration by platelet-rich plasma for age-related osteoporosis","volume":"32","author":"Liu","year":"2011","journal-title":"Biomaterials"},{"key":"key20180108022051_b42-mmr-12-02-1717","doi-asserted-by":"crossref","first-page":"C529","DOI":"10.1152\/ajpcell.00354.2005","article-title":"CGRP inhibits osteoprotegerin production in human osteoblast-like cells via cAMP\/PKA-dependent pathway","volume":"291","author":"Villa","year":"2006","journal-title":"Am J Physiol Cell Physiol"},{"key":"key20180108022051_b43-mmr-12-02-1717","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1359\/jbmr.060820","article-title":"Calcitonin deficiency in mice progressively results in high bone turnover","volume":"21","author":"Huebner","year":"2006","journal-title":"J Bone Miner Res"},{"key":"key20180108022051_b44-mmr-12-02-1717","doi-asserted-by":"crossref","first-page":"8256","DOI":"10.1016\/j.biomaterials.2012.06.088","article-title":"The role of the ERK1\/2 pathway as an alternative to the aging-diminished cyclic AMP pathway in calcitonin-mediated chondrogenesis in human nucleus pulposus","volume":"33","author":"Chen","year":"2012","journal-title":"Biomaterials"},{"key":"key20180108022051_b45-mmr-12-02-1717","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/1749-799X-5-83","article-title":"Effects of alpha-calcitonin gene-related peptide on osteoprotegerin and receptor activator of nuclear factor-\u03baB ligand expression in MG-63 osteoblast-like cells exposed to polyethylene particles","volume":"5","author":"Xu","year":"2010","journal-title":"J Orthop Surg Res"},{"key":"key20180108022051_b46-mmr-12-02-1717","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.bone.2008.10.041","article-title":"In vitro and in vivo evidence for stimulation of bone resorption by an EP4 receptor agonist and basic fibroblast growth factor: Implications for their efficacy as bone anabolic agents","volume":"44","author":"Downey","year":"2009","journal-title":"Bone"},{"issue":"Suppl 3A","key":"key20180108022051_b47-mmr-12-02-1717","doi-asserted-by":"crossref","first-page":"43S","DOI":"10.1016\/S0002-9343(00)00684-7","article-title":"Potential impact of selective cyclooxygenase-2 inhibitors on bone metabolism in health and disease","volume":"110","author":"Raisz","year":"2001","journal-title":"Am J Med"}],"container-title":["Molecular Medicine Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/mmr.2015.3637\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,9]],"date-time":"2023-08-09T14:18:20Z","timestamp":1691590700000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/mmr.2015.3637"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4,16]]},"references-count":47,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2015,4,16]]},"published-print":{"date-parts":[[2015,8]]}},"alternative-id":["10.3892\/mmr.2015.3637"],"URL":"https:\/\/doi.org\/10.3892\/mmr.2015.3637","relation":{},"ISSN":["1791-2997","1791-3004"],"issn-type":[{"value":"1791-2997","type":"print"},{"value":"1791-3004","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,4,16]]}}}